Biocon Biologics
Tata Vamsi Krishna is an experienced professional in regulatory affairs, currently serving as Team Manager at Biocon Biologics since 2022, where responsibilities include managing regulatory processes for Biosimilars in regulated markets, including preparing high-quality CMC content for various regulatory submissions and negotiations. Prior experience includes serving as Lead Manager at Caplin Steriles Limited from 2016 to 2022, overseeing operational aspects and managing sterile injectable filings, and holding the position of Senior Executive at Teva Pharmaceuticals, where streamlining development activities and exploring innovative registration processes were key responsibilities. Earlier, Tata contributed as a Senior Executive at Gland Pharma Limited, focusing on internal development of customized tools. Educational qualifications include an engineering diploma in Information Technology from TELECOM Nancy and a degree from Acharya Nagarjuna University.
This person is not in the org chart
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics